skip to content

Early Cancer Institute

 
image of Prof Utkan Demirci

We are thrilled to welcome Professor Utkan Demirci to Cambridge. Utkan joins us as a visiting Fellow Commoner of Trinity College, from Stanford University where he leads the Bio-Acoustic MEMS in Medicine (BAMM) Laboratory. His research focuses on applying micro- and nanoscale technologies to problems in medicine at the interface between micro/nanoscale engineering and medicine. For almost two decades, his work has centred on developing micro- and nano-scale technologies that address real-world medical challenges at the forefront of biomedical science.

The group’s major research focuses on creating new microfluidic technology platforms with applications to multiple diseases, including cancer, and developing new technologies for extracellular vesicle isolation and characterisation. His work has led to technologies with a substantial translational and clinical impact in various biomedical engineering fields, including global health point-of-care diagnostics, cells sorting for in-vitro fertilisation (IVF), and biofabrication. His microfluidic selection technology, Zymōt,has been employed in over 500,000 clinical cases across over 1,000 IVF clinics worldwide.

Utkan commented: “I am really happy to be here in Cambridge as a Fellow Commoner of Trinity College. During my time here, I look forward to building strong, impactful collaborations and long-lasting friendships.”

During his time in Cambridge Utkan will spend time with the Fitzgerald Group and he would be delighted to meet with colleagues to discuss the science and potential collaboration opportunities. Please get in touch if you would like to meet with Utkan.

> Read more about his work here https://profiles.stanford.edu/utkan-demirci